ACC 2025: Dapagliflozin Found Safe, Effective in Older Adults With Heart Failure Undergoing Valve Replacement
ACC 2025: Ticagrelor Antidote Restores Platelet Function, Treats Bleeding
ACC 2025: Rivaroxaban Comparable to Warfarin in Left Ventricular Blood Clots
ACC 2025: Lower-Dose Apixaban Is Effective, Safer Than Full Dose for Preventing VTE Recurrence in Patients With Cancer